Overview
- 50 inspections across 49 sites are on record.
- 150 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-18.
At a glance
Inspections
50
Sites
49
Observations
150
Career since
Jul 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Andapharm, LLC | 18 Jul 2018 | Human Drugs | View 483 → |
| Douglas Manufacturing Limited | 19 Apr 2018 | Human Drugs | On file |
| Integria Healthcare (Ballina) Pty | 12 Apr 2018 | Human Drugs | On file |
| Mayne Pharma International Pty Ltd. | 6 Apr 2018 | Human Drugs | On file |
| Dishman Biotech Limited | 29 Jan 2018 | Human Drugs |
Sites inspected
Andapharm, LLCFort Lauderdale, United States1 insp.
Douglas Manufacturing LimitedAuckland, New Zealand1 insp.
Integria Healthcare (Ballina) PtyBallina, Australia1 insp.
Mayne Pharma International Pty Ltd.Salisbury South, Australia1 insp.
Dishman Biotech LimitedAhmedabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Daveta L Bailey5 shared
Felix Maldonado4 shared
Steven P Donald4 shared
Rachel C Harrington3 shared
Susan O Oladeji2 shared
Jai P Singh2 shared
Meisha R Waters2 shared
Jennifer L Gustavus2 shared
Meisha R Sampson2 shared
John Dan2 shared
Full investigator report
Get the verbatim findings behind Tajah L Blackburn's 150 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site